rare and fatal adverse effects of lithium...

1
RARE AND FATAL ADVERSE EFFECTS OF LITHIUM INTOXICATION A. de Falco, V. Scarano, G. Cicarelli, L. Ciccone, S. Cella, D. Spitaleri U.O.C. di Neurologia e Stroke Unit – A.O.R.N. San G. Moscati - Avellino Introduzione Lithium is considered the first-line maintenance treatment for bipolar affective disorder and as a mood stabilizer in the treatment of schizoaffective disorder. Despite its therapeutic superiority and versatility, lithium has a very narrow therapeutic index and toxicity is common in patients taking this agent. Lithium intoxication (LI) generally affects the central nervous system but less frequently can affect kidneys, thyroid and parathyroid. Here we report a patient who showed neurotoxic symptoms due to LI complicated by parathyroid and renal adverse effects. Bibliografia 1.Ott, M., et al., Lithium intoxication: Incidence, clinical course and renal function - a population-based retrospective cohort study. J Psychopharmacol, 2016. 30(10): p. 1008-19. 2.Ott, M., B. Forssen, and U. Werneke, Lithium treatment, nephrogenic diabetes insipidus and the risk of hypernatraemia: a retrospective cohort study. Ther Adv Psychopharmacol, 2019. 9: p. 2045125319836563. 3.Shapiro, H.I. and K.A. Davis, Hypercalcemia and "primary" hyperparathyroidism during lithium therapy. Am J Psychiatry, 2015. 172(1): p. 12-5. 50°CONGRESSO NAZIONALE 12 - 15 OTTOBRE 2019 – BOLOGNA Caso Clinico The patient was a 52 year-old woman with a history of schizoaffective disorder on treatment with carbolithium 300 mg bid, Olanzapine 10 mg qd and clonazepam 0,5 mg qd. She also had hypertension, dyslipidemia and recent finding of hyperparathyroidism and hypercalcemia associated with parathyroid adenoma. She was admitted to our Neurology Unit for severe agitation, confusion, disorientation, akathisia, uncooperativeness and diffuse tremor. Laboratory tests showed high serum lithium (1,3 mmol/L; therapeutic range 0.6-1.2), hypercalcemia (11,6 mg/dl; normal range 8.6-10.2) and normal Na+ (138 mmol/L). EEG showed disorganization of background activity with periodic and diffuse complex of sharp waves. Brain MRI and MR-angiography were normal. Cerebrospinal fluid analysis including virologic DNA finding, bacterial antigens and cultures were unremarkable. Screening for autoimmune encephalitis was negative. Lithium was discontinued and serum calcium normalized. Agitation ceased but patent showed a persistent consciousness impairment evolving in a coma state. Laboratory revealed a gradual rise of serum Na+ up to 180 mmol/L despite a high intake of glucose 5% solutions and free water by naso-gastric tube. Diagnosis of nephrogenic diabetes insipidus (NDI) was made and patient started hemodialysis. After the first treatment Na+ serum level decreased but patient died for cardiac arrest. Discussione Neurological symptoms of LI are common and they can occur also at dosage close to therapeutic range, as in our patient, or even in the normal therapeutic range. Parathyroid and renal involvement is rare. LI can lead to hyperparathyroidism often secondary to parathyroid adenoma causing hypercalcemia which can overlap LI neurological symptoms as in our patient. Moreover, lithium toxicity can affect kidneys causing an NDI which can generate a life-threatening hypernatremia. Hemodialysis is indicated for lithium serum level > 3.5mmol/L but in case of adverse effects or poor clinical outcome it should be performed independently from lithium serum level. Conclusioni In patients with LI clinicians should identify not only neurotoxic symptoms but also rare and life-threatening adverse effects such as hypercalcemia and NDI and immediately start specific treatments. Complicanze Neurologiche Atassia, tremori, rallentamento ideo-motorio, confusione, agitazione, disturbo di coscienza Crisi epilettiche Anomalie EEG Sindrome irreversibile da tossicità da litio (SILENT) Complicanze non neurologiche Gastrointestinali nausea, vomito, diarrea Cardiache alterazioni ECG, allungamento QTc, bradicardia, aritmie Renali Insufficienza renale, Diabete insipido nefrogenico Tiroide distiroidismo, iperparatiroidismo, ipercalcemia Lithium intoxication – case series with a sample size >50 after the year 2000.

Upload: others

Post on 15-Oct-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: RARE AND FATAL ADVERSE EFFECTS OF LITHIUM …posters.neuroabstract.org/media/posters/poster_237.pdf · RARE AND FATAL ADVERSE EFFECTS OF LITHIUM INTOXICATION A. de Falco, V. Scarano,

RARE AND FATAL ADVERSE EFFECTS OF LITHIUM INTOXICATIONA. de Falco, V. Scarano, G. Cicarelli, L. Ciccone, S. Cella, D. Spitaleri

U.O.C. di Neurologia e Stroke Unit – A.O.R.N. San G. Moscati - Avellino

IntroduzioneLithium is considered the first-line maintenance treatment forbipolar affective disorder and as a mood stabilizer in thetreatment of schizoaffective disorder. Despite its therapeuticsuperiority and versatility, lithium has a very narrow therapeuticindex and toxicity is common in patients taking this agent.Lithium intoxication (LI) generally affects the central nervoussystem but less frequently can affect kidneys, thyroid andparathyroid. Here we report a patient who showed neurotoxicsymptoms due to LI complicated by parathyroid and renaladverse effects.

Bibliografia1.Ott, M., et al., Lithium intoxication: Incidence, clinical course and renal function - a population-based retrospective cohort study. J Psychopharmacol, 2016. 30(10): p. 1008-19.

2.Ott, M., B. Forssen, and U. Werneke, Lithium treatment, nephrogenic diabetes insipidus and the risk of hypernatraemia: a retrospective cohort study. Ther Adv Psychopharmacol, 2019. 9: p. 2045125319836563.

3.Shapiro, H.I. and K.A. Davis, Hypercalcemia and "primary" hyperparathyroidism during lithium therapy. Am J Psychiatry, 2015. 172(1): p. 12-5.

50°CONGRESSO NAZIONALE12 - 15 OTTOBRE 2019 – BOLOGNA

Caso ClinicoThe patient was a 52 year-old woman with a history ofschizoaffective disorder on treatment with carbolithium 300 mgbid, Olanzapine 10 mg qd and clonazepam 0,5 mg qd. She alsohad hypertension, dyslipidemia and recent finding ofhyperparathyroidism and hypercalcemia associated withparathyroid adenoma. She was admitted to our Neurology Unitfor severe agitation, confusion, disorientation, akathisia,uncooperativeness and diffuse tremor. Laboratory tests showedhigh serum lithium (1,3 mmol/L; therapeutic range 0.6-1.2),hypercalcemia (11,6 mg/dl; normal range 8.6-10.2) and normalNa+ (138 mmol/L). EEG showed disorganization of backgroundactivity with periodic and diffuse complex of sharp waves. BrainMRI and MR-angiography were normal. Cerebrospinal fluidanalysis including virologic DNA finding, bacterial antigens andcultures were unremarkable. Screening for autoimmuneencephalitis was negative. Lithium was discontinued and serumcalcium normalized. Agitation ceased but patent showed apersistent consciousness impairment evolving in a coma state.Laboratory revealed a gradual rise of serum Na+ up to 180mmol/L despite a high intake of glucose 5% solutions and freewater by naso-gastric tube. Diagnosis of nephrogenic diabetesinsipidus (NDI) was made and patient started hemodialysis. Afterthe first treatment Na+ serum level decreased but patient diedfor cardiac arrest.

DiscussioneNeurological symptoms of LI are common and they can occuralso at dosage close to therapeutic range, as in our patient, oreven in the normal therapeutic range. Parathyroid and renalinvolvement is rare. LI can lead to hyperparathyroidism oftensecondary to parathyroid adenoma causing hypercalcemia whichcan overlap LI neurological symptoms as in our patient.Moreover, lithium toxicity can affect kidneys causing an NDIwhich can generate a life-threatening hypernatremia.Hemodialysis is indicated for lithium serum level > 3.5mmol/Lbut in case of adverse effects or poor clinical outcome it shouldbe performed independently from lithium serum level.

ConclusioniIn patients with LI clinicians should identify not only neurotoxicsymptoms but also rare and life-threatening adverse effects suchas hypercalcemia and NDI and immediately start specifictreatments.

Complicanze Neurologiche

Atassia, tremori, rallentamento ideo-motorio, confusione,

agitazione, disturbo di coscienza

Crisi epilettiche

Anomalie EEG

Sindrome irreversibile da tossicità da litio (SILENT)

Complicanze non neurologiche

Gastrointestinalinausea, vomito, diarrea

Cardiachealterazioni ECG,

allungamento QTc, bradicardia, aritmie

RenaliInsufficienza renale, Diabete

insipido nefrogenico

Tiroidedistiroidismo,

iperparatiroidismo, ipercalcemia

Lithium intoxication – case series with a sample size >50 after the year 2000.